|
1
|
Dietl B, Sánchez I, Arcenillas P, Cuchi E, Gómez L, González de Molina FJ, Boix-Palop L, Nicolás J, Calbo E. Ceftolozane/tazobactam in the treatment of osteomyelitis and skin and soft-tissue infections due to extensively drug-resistant Pseudomonas aeruginosa: clinical and microbiological outcomes. Int J Antimicrob Agents 2017; 51:498-502. [PMID: 29158144 DOI: 10.1016/j.ijantimicag.2017.11.003] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2017] [Revised: 10/30/2017] [Accepted: 11/09/2017] [Indexed: 12/31/2022]
Abstract
Infections due to multidrug-resistant bacteria (MDR) are currently a clinical challenge, mainly in elderly patients. The antimicrobial spectrum, safety and efficacy of ceftolozane/tazobactam (C/T) make it an attractive option for the treatment of MDR bacterial infections beyond the indications approved to date. Here we report our experience with C/T in four cases of osteomyelitis and three cases of skin and soft-tissue infections due to extensively-drug-resistant Pseudomonas aeruginosa.
Collapse
Affiliation(s)
- B Dietl
- Infectious Diseases Unit, Internal Medicine Department, Hospital Universitari Mútua Terrassa, Plaza Dr. Robert 5, 08223 Terrassa, Barcelona, Spain.
| | - I Sánchez
- Infectious Diseases Unit, Internal Medicine Department, Hospital Universitari Mútua Terrassa, Plaza Dr. Robert 5, 08223 Terrassa, Barcelona, Spain
| | - P Arcenillas
- Pharmacy Department, Hospital Universitari Mútua Terrassa, Barcelona, Spain
| | - E Cuchi
- Department of Microbiology, CatLab, Barcelona, Spain
| | - L Gómez
- Infectious Diseases Unit, Internal Medicine Department, Hospital Universitari Mútua Terrassa, Plaza Dr. Robert 5, 08223 Terrassa, Barcelona, Spain
| | | | - L Boix-Palop
- Infectious Diseases Unit, Internal Medicine Department, Hospital Universitari Mútua Terrassa, Plaza Dr. Robert 5, 08223 Terrassa, Barcelona, Spain; Universitat Internacional de Catalunya, Barcelona, Spain
| | - J Nicolás
- Pharmacy Department, Hospital Universitari Mútua Terrassa, Barcelona, Spain
| | - E Calbo
- Infectious Diseases Unit, Internal Medicine Department, Hospital Universitari Mútua Terrassa, Plaza Dr. Robert 5, 08223 Terrassa, Barcelona, Spain; Universitat Internacional de Catalunya, Barcelona, Spain
| |
Collapse
|
|
2
|
Soriano L, Redondo S, Arcenillas P, March P, Garriga R, Pla R. DGI-059 Safety of Anti-Epidermal Growth Factor Receptor Agents: Cetuximab and Panitumumab: Abstract DGI-059 Table 1. Eur J Hosp Pharm 2013. [DOI: 10.1136/ejhpharm-2013-000276.325] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
|
3
|
Arcenillas P, Redondo S, Giménez N, March P, Soriano L, Pla R, Quintana S. OHP-047 Impact of the Economic Crisis on Biomedical Research: Analysis of the Work of a Clinical Research Ethics Committee: Abstract OHP-047 Table 1. Eur J Hosp Pharm 2013. [DOI: 10.1136/ejhpharm-2013-000276.421] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
|
4
|
Arcenillas P, Vilardell N, Soriano L, March P, Garriga R, Pla R. Medication reconciliation process in emergency department: GRP062 Table 1. Eur J Hosp Pharm 2012. [DOI: 10.1136/ejhpharm-2012-000074.62] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|